Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
100 results
  • Brain Tumors

16-517          Phase III

A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy (STELLAR Study) (View details on clinicaltrial.gov)

  • Metastatic/Advanced Cancer

16-030          Phase II

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158) (View details on clinicaltrial.gov)

  • Breast Cancer

17-521          Phase III

A Double-Blind, Placebo-Controlled, Randomized, Phase III Study of Ipataserib in Combination with Paclitaxel as a Treatment for Patients with PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer (View details on clinicaltrial.gov)

  • Leukemia

18-576          Phase II

A First-in-Human Phase 1/2a Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of FF-10101-01 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia (View details on clinicaltrial.gov)

  • Lung Cancer

19-103          Phase I

A first-in-human study for the evaluation of the safety, pharmacokinetics and antitumor activity of SAR408701 in patients with advanced solid tumors (View details on clinicaltrial.gov)

  • Cellular Therapy

18-455          Phase III

A global randomized multicenter phase 3 trial to compare the efficacy and safety of JCAR017 to standard of care in adult subjects with high-risk transplant-eligible relapsed or refractory aggressive B-cell Non-Hodgkin Lymphomas (Transform) (View details on clinicaltrial.gov)

  • Lymphoma

18-455          Phase III

A global randomized multicenter phase 3 trial to compare the efficacy and safety of JCAR017 to standard of care in adult subjects with high-risk transplant-eligible relapsed or refractory aggressive B-cell Non-Hodgkin Lymphomas (Transform) (View details on clinicaltrial.gov)

  • Head and Neck Cancer

19-217          N/A

A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201) (View details on clinicaltrial.gov)

  • Lung Cancer

19-217          N/A

A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201) (View details on clinicaltrial.gov)

Showing 1 - 10 of 100 results